National Peroxide Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	2,795	2,869	3,330
Revenue Growth (YoY)	-16.05%	-13.85%	-
Cost of Revenue	1,990	2,007	2,149
Gross Profit	805.53	861.86	1,180
Selling, General & Admin	295.56	303.03	289.6
Other Operating Expenses	411.83	406.73	514.96
Operating Expenses	911.19	910.84	997.15
Operating Income	-105.66	-48.98	183.32
Interest Expense	-15.66	-16.65	-19.82
Other Non Operating Income (Expenses)	45.97	44.87	51.63
Pretax Income	-75.36	-20.77	215.14
Income Tax Expense	-10.96	1.7	47.24
Net Income	-64.4	-22.46	167.9
Net Income to Common	-64.4	-22.46	167.9
Shares Outstanding (Basic)	6	6	6
Shares Outstanding (Diluted)	6	6	6
Shares Change (YoY)	-0.02%	-0.02%	-
EPS (Basic)	-11.21	-3.91	29.22
EPS (Diluted)	-11.21	-3.91	29.22
Free Cash Flow	-	137.78	217.7
Free Cash Flow Per Share	-	23.98	37.88
Gross Margin	28.82%	30.04%	35.45%
Operating Margin	-3.78%	-1.71%	5.50%
Profit Margin	-2.30%	-0.78%	5.04%
Free Cash Flow Margin	-	4.80%	6.54%
EBITDA	97.12	152.1	375.92
EBITDA Margin	3.47%	5.30%	11.29%
D&A For EBITDA	202.78	201.08	192.6
EBIT	-105.66	-48.98	183.32
EBIT Margin	-3.78%	-1.71%	5.50%
Effective Tax Rate	-	-	21.96%
Revenue as Reported	2,841	2,914	3,381

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.